logo
Share SHARE
FONT-SIZE Plus   Neg

Credit Suisse Unveils Organizational Changes - Quick Facts

Credit Suisse (CS) announced changes in its organizational structure and to its executive board, effective November 30, 2012. The Private Banking and Asset Management units would be combined to form the Private Banking & Wealth Management Division, while Hans-Ulrich Meister and Robert Shafir would partner in leading this division.

Hans-Ulrich Meister would be the Head of Private Banking with responsibility for running the Swiss franchise and the Private Banking client businesses in EMEA and Asia Pacific; whereas Robert Shafir would be the Head of Private Banking & Wealth Management Products, who's responsible for the current asset management products, Investment Services & Products, CS Trust and Research, as well as for the Private Banking client business in the Americas. Also, Robert Shafir would continue to serve as the CEO of the Americas region for the bank.

The Investment Banking securities platform in Switzerland would be moved into Private Banking & Wealth Management and report to Robert Shafir and to Hans-Ulrich Meister. The Solution Partners group would also jointly report to Hans-Ulrich Meister and Robert Shafir.

According to the company, the changes announced today mean that the roles of dedicated CEO Asia Pacific and EMEA no longer exist. Osama Abbasi and Fawzi Kyriakos-Saad, who serve as CEOs for those two regions, are leaving the firm. In addition, Walter Berchtold, Chairman Private Banking, has informed that he would be stepping down from his role and leave Credit Suisse after 30 years.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT